Olin (NYSE:OLN) Price Target Increased to $67.00 by Analysts at Citigroup

Olin (NYSE:OLN - Get Free Report) had its price objective upped by equities research analysts at Citigroup from $63.00 to $67.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the specialty chemicals company's stock. Citigroup's price objective would suggest a potential upside of 18.77% from the stock's previous close.

A number of other research analysts have also recently weighed in on OLN. Royal Bank of Canada lifted their target price on Olin from $58.00 to $64.00 and gave the company an "outperform" rating in a report on Monday, January 29th. The Goldman Sachs Group upped their target price on shares of Olin from $55.00 to $61.00 and gave the company a "neutral" rating in a research note on Tuesday, January 30th. Wells Fargo & Company boosted their price objective on shares of Olin from $56.00 to $60.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 3rd. Stifel Nicolaus lifted their target price on Olin from $65.00 to $66.00 and gave the stock a "buy" rating in a research report on Monday, January 29th. Finally, Barclays boosted their price target on Olin from $57.00 to $59.00 and gave the stock an "equal weight" rating in a research note on Thursday, April 4th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $59.00.

Olin Trading Down 3.9 %

Shares of Olin stock traded down $2.31 during trading hours on Wednesday, reaching $56.41. 880,373 shares of the company's stock were exchanged, compared to its average volume of 1,048,589. The firm has a market capitalization of $6.75 billion, a price-to-earnings ratio of 15.94, a price-to-earnings-growth ratio of 0.32 and a beta of 1.44. The company has a current ratio of 1.29, a quick ratio of 0.73 and a debt-to-equity ratio of 1.14. Olin has a 52-week low of $41.71 and a 52-week high of $60.60. The company has a fifty day moving average of $54.98 and a 200-day moving average of $51.12.

Olin (NYSE:OLN - Get Free Report) last released its earnings results on Thursday, January 25th. The specialty chemicals company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.10. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.50 billion. Olin had a return on equity of 18.44% and a net margin of 6.74%. Sell-side analysts forecast that Olin will post 3.75 EPS for the current fiscal year.

Insider Transactions at Olin

In other Olin news, CEO Scott Mcdougald Sutton sold 48,896 shares of the firm's stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $52.39, for a total value of $2,561,661.44. Following the sale, the chief executive officer now owns 90,327 shares in the company, valued at $4,732,231.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Todd A. Slater sold 63,250 shares of the company's stock in a transaction that occurred on Tuesday, January 30th. The shares were sold at an average price of $54.15, for a total value of $3,424,987.50. Following the completion of the sale, the chief financial officer now directly owns 137,517 shares of the company's stock, valued at approximately $7,446,545.55. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Scott Mcdougald Sutton sold 48,896 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $52.39, for a total transaction of $2,561,661.44. Following the completion of the transaction, the chief executive officer now owns 90,327 shares of the company's stock, valued at $4,732,231.53. The disclosure for this sale can be found here. Over the last quarter, insiders sold 753,274 shares of company stock worth $40,434,124. Insiders own 1.80% of the company's stock.

Institutional Investors Weigh In On Olin

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in shares of Olin by 3.2% during the first quarter. Vanguard Group Inc. now owns 15,867,281 shares of the specialty chemicals company's stock valued at $829,542,000 after purchasing an additional 493,052 shares during the last quarter. Hotchkis & Wiley Capital Management LLC increased its holdings in shares of Olin by 3.2% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 6,602,331 shares of the specialty chemicals company's stock valued at $356,196,000 after purchasing an additional 203,260 shares during the period. State Street Corp lifted its position in shares of Olin by 0.6% in the first quarter. State Street Corp now owns 5,581,714 shares of the specialty chemicals company's stock worth $291,812,000 after purchasing an additional 31,587 shares in the last quarter. Boston Partners boosted its holdings in shares of Olin by 122.8% during the fourth quarter. Boston Partners now owns 5,029,377 shares of the specialty chemicals company's stock worth $271,152,000 after purchasing an additional 2,772,274 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Olin by 3.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,635,983 shares of the specialty chemicals company's stock valued at $196,167,000 after purchasing an additional 126,587 shares in the last quarter. 88.67% of the stock is currently owned by institutional investors.

About Olin

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.